Literature DB >> 32557014

18F-FDG uptake as a predictive factor for progressive aortic enlargement in aortic dissection.

Takatoshi Higashigawa1, Yasutaka Ichikawa2, Shuji Chino3, Ken Nakajima3, Takafumi Ouchi2, Hiroaki Kato2, Koji Hirano4, Toshiya Tokui4, Noriyuki Kato2, Hajime Sakuma2.   

Abstract

OBJECTIVE: Progressive aortic enlargement (PAE) is a critical adverse event in patients with medically treated aortic dissection (AD). However, no reliable predictor of the PAE has been established. The purpose of this study was to evaluate the value of 18F-FDG PET/CT for the prediction of PAE in patients with medically treated AD.
METHODS: Sixteen patients with AD who underwent optimal medical therapy were enrolled. 18F-FDG PET/CT examinations were performed in subacute phase (2 weeks-3 months) after the onset of AD. Target-to-background ratio (TBR) was measured as the maximum standardized uptake value (SUV) in the dissected aortic wall divided by blood pool SUV. The relation between TBR and occurrence of PAE (> 10 mm/year) was evaluated.
RESULTS: PAE was observed in four patients during the median follow-up period of 24 months. The TBR measured in the 4 patients showing PAE was significantly higher than that in the remaining 12 patients without PAE (2.44 ± 0.56 vs 1.87 ± 0.33, P = 0.025). The area under the receiver operating characteristic curve of TBR for predicting PAE was 0.82. With a threshold of 2.34, the TBR showed the sensitivity, specificity, and positive and negative predictive value of 75%, 92%, 75%, and 92%, respectively, for the prediction of PAE.
CONCLUSIONS: Higher 18F-FDG uptake in the dissected aortic wall as determined by TBR is associated with increased risk of PAE in patients with medically treated AD. TBR shows good specificity and negative predictive value for predicting PAE.

Entities:  

Keywords:  18F-FDG; Aortic dissection; PET/CT; Progressive aortic enlargement

Mesh:

Substances:

Year:  2020        PMID: 32557014     DOI: 10.1007/s12149-020-01487-2

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  2 in total

1.  Clinical profiles and outcomes of acute type B aortic dissection in the current era: lessons from the International Registry of Aortic Dissection (IRAD).

Authors:  Toru Suzuki; Rajendra H Mehta; Hüseyin Ince; Ryozo Nagai; Yasunari Sakomura; Frank Weber; Tetsuya Sumiyoshi; Eduardo Bossone; Santi Trimarchi; Jeanna V Cooper; Dean E Smith; Eric M Isselbacher; Kim A Eagle; Christoph A Nienaber
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

2.  Computed Tomography Imaging Features in Acute Uncomplicated Stanford Type-B Aortic Dissection Predict Late Adverse Events.

Authors:  Anna M Sailer; Sander M J van Kuijk; Patricia J Nelemans; Anne S Chin; Aya Kino; Mark Huininga; Johanna Schmidt; Gabriel Mistelbauer; Kathrin Bäumler; Peter Chiu; Michael P Fischbein; Michael D Dake; D Craig Miller; Geert Willem H Schurink; Dominik Fleischmann
Journal:  Circ Cardiovasc Imaging       Date:  2017-04       Impact factor: 7.792

  2 in total
  2 in total

1.  A methylprednisolone-loaded and core-shell nanofiber-covered stent-graft to prevent inflammation and reduce degradation in aortic dissection.

Authors:  Junjun Liu; Hongqiao Zhu; Yifei Pei; Jian Zhou; Zaiping Jing; Heng Zhang
Journal:  Biomater Res       Date:  2022-04-25

2.  Time-related aortic inflammatory response, as assessed with 18F-FDG PET/CT, in patients hospitalized with severely or critical COVID-19: the COVAIR study.

Authors:  Charalambos Vlachopoulos; Dimitrios Terentes-Printzios; Paraskevi Katsaounou; Eirini Solomou; Vasiliki Gardikioti; Dimitrios Exarchos; Dimitrios Economou; Georgia Christopoulou; Antonios-Dimosthenis Kalkinis; Pavlos Kafouris; Alexios Antonopoulos; Georgios Lazaros; Anastasia Kotanidou; Ioannis Datseris; Konstantinos Tsioufis; Constantinos Anagnostopoulos
Journal:  J Nucl Cardiol       Date:  2022-05-02       Impact factor: 3.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.